Tratamentul cu Imupurin şi Imuheptin al pacienţilor cu ciroză hepatică de etiologie

Abstract

Assessment of the evolution of clinical, biochemical and immunological parameters in patients with liver cirrhosis under the influence of treatment with Imuheptin and Imupurin was the purpose of this study. After 3 months of treatment was found complete regression or decrease of clinical signs and syndroms: dyspepsic and astenovegetativ syndroms. The results of laboratory investigations confirmed the positive evolution of clinical signs. Decrease of ALT activity in all monitored patients were found and decrease of CIC. During the study all patients established good tolerability of the administered medication.